• AMPK Restricts ULK1-Driven Autophagy Under Energy Stress

  2026-05-24

  This study overturns the prevailing model of autophagy regulation by demonstrating that AMPK inhibits, rather than activates, ULK1 and autophagy during cellular energy stress. These findings reshape our understanding of autophagy signaling and highlight crucial implications for experimental design and interpretation in autophagy research.

• Practical Guidance for Nigericin Sodium Salt in Ion Transpor

  2026-05-23

  Nigericin sodium salt is a potassium ionophore designed for rapid and selective ion transport studies, especially where cytoplasmic pH regulation, lead (Pb2+) transport specificity, or platelet aggregation modulation are central endpoints. It is best suited for short-term, controlled applications requiring precise ionic manipulation. Its use is not recommended in protocols dependent on aqueous solubility or long-term solution stability.

• Bafilomycin A1 in Nanomedicine: Advancing V-ATPase Inhibitio

  2026-05-22

  Explore how Bafilomycin A1, a potent V-ATPase inhibitor, is reshaping nanomedicine and mRNA delivery research. This article uniquely bridges intracellular acidification control with next-generation nanoparticle-based therapeutics.

• Clozapine N-oxide: Precision Chemogenetics for Neuronal Modu

  2026-05-22

  Clozapine N-oxide (CNO) is the gold-standard chemogenetic actuator, enabling highly selective and reversible neuronal activity modulation in vivo and in vitro. This article demystifies CNO’s workflow integration, protocol fine-tuning, and troubleshooting for advanced neuroscience research, with actionable insights inspired by cutting-edge hippocampal targeting studies.

• Angiotensin II-HIF-1α Axis Drives Radioresistance in NPC

  2026-05-21

  This study elucidates how local angiotensin II (Ang II) promotes radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis via the HIF-1α-HILPDA axis. The findings highlight actionable molecular targets to improve radiotherapy efficacy and suggest that combined inhibition of Ang II signaling and induction of ferroptosis may enhance NPC radiosensitivity.

• Carfilzomib (PR-171): Proteasome Inhibition in Epigenetic Th

  2026-05-21

  Explore how Carfilzomib (PR-171) enables advanced proteasome inhibition in cancer research, with a unique focus on its role in epigenetic therapy and combinatorial strategies. Uncover protocol nuances, new synergy insights, and translational implications.

• Verbascoside: Precision PKC/NF-κB Inhibitor for Osteoclastog

  2026-05-20

  Verbascoside from APExBIO offers targeted PKC/NF-κB pathway inhibition, enabling high-fidelity dissection of osteoclastogenesis and neuroinflammatory processes. Its robust solubility and validated IC50 in RANKL-induced cellular models accelerate reproducible, mechanism-focused research.

• Balsalazide Disodium Dihydrate: Optimizing Inflammation Rese

  2026-05-20

  Balsalazide Disodium Dihydrate unlocks robust, localized anti-inflammatory effects, making it ideal for dissecting pathomechanisms in ulcerative colitis and immunology assays. This guide delivers actionable workflows, protocol specifics, and troubleshooting strategies grounded in peer-reviewed data and product-driven evidence.

• CKI 7 dihydrochloride: Reliable CK1 Inhibition for Cell Assa

  2026-05-19

  CKI 7 dihydrochloride (SKU B4936) enables robust, reproducible inhibition of Casein kinase 1 in cell viability, proliferation, and cytotoxicity assays. This article addresses common workflow pain points and illustrates, through data-driven scenarios, how CKI 7 dihydrochloride outperforms alternatives in sensitivity, selectivity, and compatibility for signaling pathway research.

• T7 RNA Polymerase: Optimizing In Vitro RNA Synthesis Workflo

  2026-05-19

  Harness APExBIO’s T7 RNA Polymerase for high-yield, template-specific RNA synthesis, enabling advanced applications from RNA vaccine production to functional RNA research. Groundbreaking insights from recent lung cancer immunotherapy studies guide practical protocol enhancements, troubleshooting, and translational innovations.

• Phosbind Acrylamide: Precision Phosphate-Binding Reagent for

  2026-05-18

  Phosbind Acrylamide streamlines SDS-PAGE-based protein phosphorylation analysis by enabling antibody-free, high-resolution separation of phosphorylated and non-phosphorylated proteins. Its robust phosphate specificity and workflow flexibility empower researchers to dissect dynamic phosphorylation signaling, such as the Fus3-MAPK/RNS1 cascade in fungi, with clarity and reproducibility.

• Polyethylenimine Linear: High-Efficiency Transfection for In

  2026-05-18

  Polyethylenimine Linear (PEI), MW 40,000, stands out as a gold-standard DNA transfection reagent, enabling scalable, serum-compatible gene delivery from 96-well plates to bioreactors. This article details experimental workflows, troubleshooting insights, and protocol optimizations that maximize reproducibility and yield, drawing on cutting-edge research and real-world lab experience.

• Molidustat (BAY85-3934): Redefining HIF Stabilization in Ren

  2026-05-17

  Explore the advanced science behind Molidustat (BAY85-3934), a novel HIF-PH inhibitor for renal anemia therapy. This article uniquely dissects its mechanistic nuance, real-world protocol implications, and the pivotal role of HIF-1α regulation—offering insights not covered in prior reviews.

• V5 Epitope Tag Peptide: Workflow Optimization and Troublesho

  2026-05-16

  Leverage the V5 Epitope Tag Peptide for high-fidelity protein detection, purification, and single-molecule imaging. This guide details applied workflows, real-world troubleshooting, and new screening advances, positioning APExBIO’s V5 tag as a gold standard for reproducible, multiplexed molecular biology.

• Enhancing Kidney-Targeted mRNA Nanoparticles via Excipients

  2026-05-15

  This study investigates the use of various excipients to increase the mRNA loading capacity of polymeric mesoscale nanoparticles targeting the kidney. By systematically evaluating how excipient selection influences encapsulation efficiency, cytotoxicity, and functional delivery, the research provides new insights for optimizing mRNA-based therapies in renal disease contexts.

15892 records 1/1060 page Next 12345 下5页 Last page